Search for:
About us
Leadership team
Virtual tour
Direction and location
Code of Conduct and Ethics
Services
Bioprocess development (USP & DSP)
cGMP manufacturing of clinical & commercial batches
Analytical Development, Qualification & Validation – QC & QA
Fill & Finish
Regulatory Support
Our platforms
LentiSure™: Lentivirus Manufacturing Platform
AAV manufacturing platform
Innovation
News, blog & events
News
Blog
Events
Careers
Contact us
Search for:
News
All
News
Blog
Events
‘Choose France’ Yposkesi welcomes French Ministers to newly constructed 5,000m2 site – under government scheme
15 May 2023
Read more
Yposkesi launches LentiSure™, Lentiviral (LV) Vector production platform optimized for higher yields
5 April 2023
Read more
Yposkesi reinforces team with three executive appointments
12 July 2022
Read more
ASMA Consortium: Improving access to innovative bio therapeutics through acoustic technologies
22 February 2022
Read more
Yposkesi launches construction of its second bioproduction site.
14 June 2021
Read more
Yposkesi welcomes SK Group as new majority equity shareholder, forging solid industrial partnership for growth.
31 March 2021
Read more
Apres le Génopole, Novartis choisit l’Essonne pour ses therapies géniques
9 December 2020
Read more
Yposkesi welcomes Brian Mullan, PhD, as director of innovation, analytical and process development
8 December 2020
Read more
Yposkesi welcomes Patrick Lansky as VP of US sales & marketing
2 March 2020
Read more
Yposkesi’s clinical batches of G1XCGD lentiviral vector used in rare immune system disease study
30 January 2020
Read more
Load more News
Would you like to know more ?
Contact us